User login
This week (July 13, 2017) the US Senate released the next iteration of Repeal and Replace. Most involved in health care delivery oppose Medicaid cuts, relaxation of insurance coverage regulations, making the essential benefit set optional, and other parts of this legislation. Although most Americans oppose this legislation, if I were a hedge fund manager, I would be shorting the ACA.
The Editors have gathered an eclectic group of articles for your education and reading pleasure. On the cover, you read about threats from cybercrime, research questioning the safety of long-term use of proton pump inhibitors (I am going on my 20th year of a PPI) and a story about physician burnout.
Be sure and read about the new reversal agent for dabigatran (Pradaxa) – something we have been waiting for. It turns out that SUNSHINE (vitamin D) may be helpful in metastatic colon cancer. Relatives of NAFLD patients are at increased risk of NAFLD themselves and liver disease doubles the risk of colon cancer. EASL published new PBC guidelines.
From the Annals of Internal Medicine, we summarize a large retrospective study again linking interval colon cancers with polypectomy rates of physicians performing screening colonoscopy. The unique twist here is that African American patients tended to be examined by physicians with lower ADR’s compared to whites and they indeed had higher interval cancer rates. We must advocate for reduction in avoidable variations in health outcomes tied to diversity.
We are beginning to present summaries of AGA Presidential Plenary presentations, led off by my colleague from Michigan, Anna Lok (current President of the AASLD). I hope you enjoy this series.
We end this month’s issue with an article I wrote for CGH entitled, “From Obamacare to Trumpcare: Implications for gastroenterologists”. If you have not guessed, the implications are substantial.
John I. Allen, MD, MBA, AGAF
Editor in Chief
This week (July 13, 2017) the US Senate released the next iteration of Repeal and Replace. Most involved in health care delivery oppose Medicaid cuts, relaxation of insurance coverage regulations, making the essential benefit set optional, and other parts of this legislation. Although most Americans oppose this legislation, if I were a hedge fund manager, I would be shorting the ACA.
The Editors have gathered an eclectic group of articles for your education and reading pleasure. On the cover, you read about threats from cybercrime, research questioning the safety of long-term use of proton pump inhibitors (I am going on my 20th year of a PPI) and a story about physician burnout.
Be sure and read about the new reversal agent for dabigatran (Pradaxa) – something we have been waiting for. It turns out that SUNSHINE (vitamin D) may be helpful in metastatic colon cancer. Relatives of NAFLD patients are at increased risk of NAFLD themselves and liver disease doubles the risk of colon cancer. EASL published new PBC guidelines.
From the Annals of Internal Medicine, we summarize a large retrospective study again linking interval colon cancers with polypectomy rates of physicians performing screening colonoscopy. The unique twist here is that African American patients tended to be examined by physicians with lower ADR’s compared to whites and they indeed had higher interval cancer rates. We must advocate for reduction in avoidable variations in health outcomes tied to diversity.
We are beginning to present summaries of AGA Presidential Plenary presentations, led off by my colleague from Michigan, Anna Lok (current President of the AASLD). I hope you enjoy this series.
We end this month’s issue with an article I wrote for CGH entitled, “From Obamacare to Trumpcare: Implications for gastroenterologists”. If you have not guessed, the implications are substantial.
John I. Allen, MD, MBA, AGAF
Editor in Chief
This week (July 13, 2017) the US Senate released the next iteration of Repeal and Replace. Most involved in health care delivery oppose Medicaid cuts, relaxation of insurance coverage regulations, making the essential benefit set optional, and other parts of this legislation. Although most Americans oppose this legislation, if I were a hedge fund manager, I would be shorting the ACA.
The Editors have gathered an eclectic group of articles for your education and reading pleasure. On the cover, you read about threats from cybercrime, research questioning the safety of long-term use of proton pump inhibitors (I am going on my 20th year of a PPI) and a story about physician burnout.
Be sure and read about the new reversal agent for dabigatran (Pradaxa) – something we have been waiting for. It turns out that SUNSHINE (vitamin D) may be helpful in metastatic colon cancer. Relatives of NAFLD patients are at increased risk of NAFLD themselves and liver disease doubles the risk of colon cancer. EASL published new PBC guidelines.
From the Annals of Internal Medicine, we summarize a large retrospective study again linking interval colon cancers with polypectomy rates of physicians performing screening colonoscopy. The unique twist here is that African American patients tended to be examined by physicians with lower ADR’s compared to whites and they indeed had higher interval cancer rates. We must advocate for reduction in avoidable variations in health outcomes tied to diversity.
We are beginning to present summaries of AGA Presidential Plenary presentations, led off by my colleague from Michigan, Anna Lok (current President of the AASLD). I hope you enjoy this series.
We end this month’s issue with an article I wrote for CGH entitled, “From Obamacare to Trumpcare: Implications for gastroenterologists”. If you have not guessed, the implications are substantial.
John I. Allen, MD, MBA, AGAF
Editor in Chief
